| Erik Holt, | |
|
214 E 23rd St, Upmc Shadyside Hospital, Cheyenne, WY 82001-3748 | |
| (307) 634-2273 | |
| Not Available |
| Full Name | Erik Holt |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 214 E 23rd St, Cheyenne, Wyoming |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073586533 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 7174A (Wyoming) | Primary |
| Entity Name | University Of Pittsburgh Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1619935004 PECOS PAC ID: 8729990239 Enrollment ID: O20040308000883 |
News Archive
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.
Children with chronic health conditions such as cystic fibrosis, type 1 diabetes, sickle cell diseases and cerebral palsy represent less than two percent of the population but can consume more than 50 percent of resources at children's hospitals throughout the country. Coordinating care for these children has historically been difficult because hospitals have varying methods to identify them in their systems.
Oramed Pharmaceuticals Inc. announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.
Russian scientists have found that neoadjuvant chemotherapy in patients with breast cancer can stimulate evolution of the tumor. The results of the research conducted by Nicholay Litvyakov, D.Sc. at Cancer Research Institute, Head of the Tumor Virology Laboratory, and TSU researcher Marina Ibragimova, were published in "Siberian Journal of Oncology."
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erik Holt, 7851 S Elati St, Suite 202, Littleton, CO 80120-8080 Ph: () - | Erik Holt, 214 E 23rd St, Upmc Shadyside Hospital, Cheyenne, WY 82001-3748 Ph: (307) 634-2273 |
News Archive
A new finding provides fresh hope for the millions of women worldwide with oestrogen receptor positive breast cancer. Australian scientists have shown that a specific change, which occurs when tumours become resistant to anti-oestrogen therapy, might make the cancers susceptible to treatment with chemotherapy drugs.
The first advance in pancreatic cancer treatment in a decade has been achieved by researchers in a Canadian-led study, and at last gives some encouragement to scientists and invigorates a field that has experienced more than its share of disheartening failures.
Children with chronic health conditions such as cystic fibrosis, type 1 diabetes, sickle cell diseases and cerebral palsy represent less than two percent of the population but can consume more than 50 percent of resources at children's hospitals throughout the country. Coordinating care for these children has historically been difficult because hospitals have varying methods to identify them in their systems.
Oramed Pharmaceuticals Inc. announced today successful results in an exploratory clinical trial testing the effectiveness of its oral insulin capsule (ORMD-0801) in Type I diabetes patients suffering from uncontrolled diabetes.
Russian scientists have found that neoadjuvant chemotherapy in patients with breast cancer can stimulate evolution of the tumor. The results of the research conducted by Nicholay Litvyakov, D.Sc. at Cancer Research Institute, Head of the Tumor Virology Laboratory, and TSU researcher Marina Ibragimova, were published in "Siberian Journal of Oncology."
› Verified 2 days ago
Bryan K Beck, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Dr. Kathern L Auer, D.O. Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Dr. Rebecca Kay Carney Calisch, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 | |
Daniel E Surdam, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 | |
Dr. Jessica Florence Jane Hughes, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 214 E 23rd St, Dept. Of Emergency Medicine, Cheyenne, WY 82001 Phone: 307-633-7670 Fax: 307-633-7469 | |
Eldon M Handrich, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 214 E 23rd St, Cheyenne, WY 82001 Phone: 307-634-2273 Fax: 307-633-7671 |